CG Oncology (CGON) Assets (2023 - 2026)

CG Oncology (CGON) has 4 years of Assets data on file, last reported at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 55.9% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 55.9% YoY), and the FY2025 full-year result was $791.6 million, up 4.87% from the prior year.
• Assets for Q1 2026 stood at $1.1 billion, up from $791.6 million in the prior quarter.
• Across five years, Assets topped out at $1.1 billion in Q1 2026 and bottomed at $199.3 million in Q4 2023.
• The 4-year median for Assets is $714.8 million (2025), against an average of $673.6 million.
• The widest annual swing landed in 2024, when Assets soared 278.72%; it then gained 4.87% in 2025.
• A 4-year view of Assets shows it stood at $199.3 million in 2023, then jumped by 278.72% to $754.8 million in 2024, then increased by 4.87% to $791.6 million in 2025, then surged by 43.42% to $1.1 billion in 2026.
• The last three Assets figures came in at $1.1 billion (Q1 2026), $791.6 million (Q4 2025), and $729.9 million (Q3 2025), per Business Quant data.

Peer Comparison